CVRX250117C15000
- 0.25
- 0.000.00%
CVRx Inc Newsroom
Institutions Own 39% of CVRx, Inc. (NASDAQ:CVRX) Shares but Private Equity Firms Control 39% of the Company
Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $19
Evaluating CVRx: Insights From 6 Financial Analysts
CCORF Maintains CVRx Inc(CVRX.US) With Buy Rating, Raises Target Price to $22
Express News | CVRx Inc : Canaccord Genuity Raises Target Price to $22 From $17
Top Premarket Decliners
Cvrx (CVRX) Declined Due To Turbulence In The Direct Sales Team
CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference
Broadcom To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
Craig-Hallum Maintains CVRx Inc(CVRX.US) With Buy Rating, Announces Target Price $20
Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Raises Target Price to $19
Express News | CVRx: Apc Payment of About $45,000 Will Continue in 2025
CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025
10 Health Care Stocks Moving In Monday's Pre-Market Session
CVRx, Inc. (NASDAQ:CVRX) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
CVRx Inc | 10-Q: Q3 2024 Earnings Report
Piper Sandler Reiterates Overweight on CVRx, Raises Price Target to $16
CVRx Analyst Ratings
CVRx Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Revenue Results.
Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Raises Target Price to $15